Catharine Wang
Profiles

Catharine Wang, PhD

Professor, Community Health Sciences - Boston University School of Public Health

617-358-1475
clwang@bu.edu
Crosstown Center - 451
View Full Profile at BUMC

Biography

Dr. Wang is a Professor in the Community Health Sciences Department, and a Peter T. Paul Career Development Professor, at Boston University. She obtained her doctorate in Health Behavior and Health Education from the University of Michigan and has expertise in mixed-methods research, intervention development, and program evaluation. Her research has spanned across several areas including health communication/digital health, health literacy, public health genomics, and cancer care implementation and delivery. Dr. Wang currently serves as a member of the National Cancer Institute's PDQ Cancer Genetics Editorial Board.

Dr. Wang has over 20 years of experience in studying the ethical, legal, and social implications (ELSI) of genomic advances. Her work exemplifies her commitment to mitigating health disparities via accessible information, interventions, and services. Dr. Wang has been the Principal Investigator on multiple grants examining various ELSI topic areas including (a) communication of genetic risk, (b) barriers to genetic literacy among underserved populations, and (c) adoption and use of genetic testing. Her ongoing research continues to examine how underrepresented and vulnerable populations comprehend and engage with population-based efforts to facilitate greater access to genetic information and services.

Dr. Wang currently teaches SB821: Intervention Strategies for Health Promotion.

Other Positions

  • Member, BU-BMC Cancer Center - Boston University
  • Member, Genome Science Institute - Boston University

Education

  • University of Michigan at Ann Arbor, PhD Field of Study: Social & Behavioral Sciences
  • University Waterloo, MSc Field of Study: Social & Behavioral Sciences

Websites

Classes Taught

  • SPHSB821

Publications

  • Published on 11/29/2024

    Zayhowski K, Wang C, Nahorniak M, Loo S, Gignac G, Gunn C. A qualitative study of the experiences of patients with prostate cancer when receiving negative genetic results: "I still don't have a grasp of what it all means". J Genet Couns. 2024 Nov 29. PMID: 39611226.

     Read At: PubMed
  • Published on 10/28/2024

    Conner S, Theoryn T, Dusic E, Beers F, Knerr S, Norquist B, Shirts BH, Bowen D, Swisher EM, Wang C. Primary care provider practices, attitudes, and confidence with hereditary cancer risk assessment and testing: A mixed methods study. Genet Med. 2024 Oct 28; 101307. PMID: 39484797.

     Read At: PubMed
  • Published on 6/6/2024

    Sud M, Stallings E, Wang C, Sosa LT. A qualitative study of Black breast cancer previvors' and survivors' experiences after positive genetic testing. J Genet Couns. 2024 Jun 06. PMID: 38845384.

     Read At: PubMed
  • Published on 4/9/2024

    Franca K, Swenson KB, Wang C. Counseling in a different language: An analysis of experiences and resources in multilingual genetic counseling. J Genet Couns. 2024 Apr 09. PMID: 38594719.

     Read At: PubMed
  • Published on 1/9/2024

    Wagner IM, Xuan Z, Lu H, Wang C. Racial Disparities in Accessing Care along the Continuum of Cancer Genetic Service Delivery. Cancer Epidemiol Biomarkers Prev. 2024 Jan 09; 33(1):55-62. PMID: 37819271.

     Read At: PubMed
  • Published on 12/5/2023

    Delgado IS, Outterson A, Ramesh V, Amador Sanchez AG, Boza AC, Lopez-Pilarte D, Amador Velázquez JJ, Friedman DJ, Brooks DR, Scammell MK, Wang C. Ethical considerations for genetic research in low-income countries: perceptions of informed consent, data sharing, and expectations in Nicaragua. Eur J Hum Genet. 2024 Oct; 32(10):1278-1284. PMID: 38052907.

     Read At: PubMed
  • Published on 7/27/2023

    Wang C, Bertrand KA, Trevino-Talbot M, Flynn M, Ruderman M, Cabral HJ, Bowen DJ, Hughes-Halbert C, Palmer JR. Ethical, legal, and social implications (ELSI) and challenges in the design of a randomized controlled trial to test the online return of cancer genetic research results to U.S. Black women. Contemp Clin Trials. 2023 Sep; 132:107309. PMID: 37516165.

     Read At: PubMed
  • Published on 6/29/2023

    Gunn CM, Gignac G, Hardy B, Zayhowski K, Pankowska M, Loo S, Wang C. Characterizing Referrals for Prostate Cancer Genetic Services in a Safety-Net Hospital. JCO Oncol Pract. 2023 Oct; 19(10):852-859. PMID: 37384869.

     Read At: PubMed
  • Published on 2/11/2023

    Wang C, Lu H, Bowen DJ, Xuan Z. Implementing digital systems to facilitate genetic testing for hereditary cancer syndromes: An observational study of 4 clinical workflows. Genet Med. 2023 May; 25(5):100802. PMID: 36906849.

     Read At: PubMed
  • Published on 1/1/2023

    Gunn CM, Li EX, Gignac GA, Pankowska M, Loo S, Zayhowski K, Wang C. Delivering Genetic Testing for Patients with Prostate Cancer: Moving Beyond Provider Knowledge as a Barrier to Care. Cancer Control. 2023; 30:10732748221143884. PMID: 36946278.

     Read At: PubMed

View 58 more publications:View Full Profile at BUMC

News & In the Media

View all profiles